Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma

N Engl J Med. 2015 Nov 12;373(20):1984. doi: 10.1056/NEJMc1508163.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • CTLA-4 Antigen / antagonists & inhibitors*
  • Female
  • Humans
  • Male
  • Melanoma / genetics*
  • Skin Neoplasms / genetics*

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • CTLA-4 Antigen